6-Bromo-1-hexanol (CAS NO : 4286-55-9)

6-Bromo-1-hexanol (CAS No: 4286-55-9) acts as a versatile bifunctional building block in the high-growth specialty chemical sector, where its terminal hydroxyl and bromide groups facilitate the precise introduction of C6 spacers in complex molecular architectures. Within the pharmaceutical CDMO market, this intermediate is gaining significant traction as a critical reagent for the synthesis of nitric oxide-donating NSAID analogues, such as modified Sulindac derivatives, which are currently being investigated for enhanced efficacy in oncology applications. Furthermore, the compound is increasingly utilised in advanced materials science for the click-chemistry-driven synthesis of branched oligonucleotides and the development of polymerisable ionic liquids for next-generation gel polymer electrolytes, reflecting a broadening demand across proteomics research and high-performance polymer industries. As a globally established 6-Bromo-1-hexanol supplier with 99% purity, we ensure dependable supply, consistent quality, and complete regulatory documentation, including 6-Bromo-1-hexanol CoA and 6-Bromo-1-hexanol TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.